Thus, in this cohort of BE patients with no dysplasia, p53 loss did not bear prognostic potential, which is in contrast to findings in Barrett cohorts that also included patients with low- and high-grade dysplasia16, 20, 21, 22. This evidence concerns the gene TP53 and Barrett esophagus.